Legislative Update: February 12, 2019
Over the last week, lawmakers and the Trump Administration have continued to discuss proposals to avert the upcoming February 15th appropriations deadline.
If no funding deal is struck by the end of the day on Friday, the government would enter another partial shutdown. Reports have suggested that negotiators are making progress on reaching a deal, but it remains unclear how or when a proposal will be finalized.
In the meantime, key Congressional Committees have held a series of hearings–and plan to hold more–on health care related issues.
Hearings last week included a hearing in the House Energy & Commerce Committee that focused on the potential implications of the TX vs. USA legal case related to the Affordable Care Act (ACA). If the lawsuit is upheld, it has the potential to render all or parts of ACA unconstitutional, which could lead to significant disruption in the health care market. The case is making its way through the court system and lawmakers continue to monitor its potential impact.
The House Education & Labor Committee also held a health insurance related hearing last week. The focus of this hearing was reviewing health insurance options and considerations for patients with preexisting medical conditions.
At the same time, lawmakers continued to focus on the issue of prescription drug costs. The House Ways & Means Committee announced a new hearing on the topic, slated for today, February 12th. This follows a series of other recent hearings across both the House and Senate on the issue of drug pricing.
We will continue to provide updates on how the funding appropriations deadline and key health policy activities could impact our members in the coming weeks.